by University of Eastern Finland Credit: CC0 Public Domain A study led by the University of Eastern Finland found that better physical condition and higher daily activity predicted lower levels of fatigue in patients with relapsing-remitting multiple sclerosis, RRMS. A lower disability rate was also associated with less fatigue. The study was published in the journal Multiple...
by CU Anschutz Medical Campus Credit: Pixabay/CC0 Public Domain An article published in the Lancet Neurology journal evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies. Multiple sclerosis (MS) is a chronic illness, often presenting in young adulthood. Most commonly, at onset, individuals have acute attacks, or relapses,...
Kelli Whitlock Burton November 07, 2022 An internet-based cognitive-behavioral therapy (iCBT) program specifically designed for patients with multiple sclerosis (MS) significantly reduced depressive symptoms compared to usual treatment, new research shows. Participants in the randomized controlled trial who received iCBT either alone or in combination with weekly emails from therapists reported benefits that persisted up to a year after...
by University at Buffalo Credit: Pixabay/CC0 Public Domain Brain lesions—areas of brain tissue that show damage from injury or disease—are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led by the University at Buffalo strongly suggests that the volume of white matter lesions is neither proportional to...
Kelli Whitlock Burton November 07, 2022 An internet-based cognitive-behavioral therapy (iCBT) program specifically designed for patients with multiple sclerosis (MS) significantly reduced depressive symptoms compared to usual treatment, new research shows. Participants in the randomized controlled trial who received iCBT either alone or in combination with weekly emails from therapists reported benefits that persisted up...
by Ellen Goldbaum, University at Buffalo Credit: BruceBlaus/Wikimedia Commons, CC BY-SA 4.0 In recent years, new drugs to treat multiple sclerosis have significantly improved both the quality of life and longevity for patients with MS. Many of them now live well into their 60s and70s, a significant improvement from just a generation ago when few...
